Skip to content

A Single Centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery

Prospective Single-centre, Uncontrolled, Post Marketing Surveillance Study to Monitor the Long-term Performance of the DePuy ASR™ Hip in Subjects With Suitable Indications for a Primary Resurfacing Hip Arthroplasty

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00872794
Enrollment
50
Registered
2009-03-31
Start date
2003-11-30
Completion date
2010-05-31
Last updated
2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avascular Necrosis, Collagen Disorders, Congenital Hip Dysplasia, Nonunion of Femoral Fractures, Osteoarthritis, Post-traumatic Arthritis, Rheumatoid Arthritis, Slipped Capital Femoral Epiphysis

Keywords

Hip, Conservative, Metal on Metal, Resurfacing

Brief summary

The purpose of this study is to monitor the performance and determine the metal ion release of the DePuy ASR™ System in the treatment of patients with hip joint disease requiring hip resurfacing surgery. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. A subset of patients will also have blood samples taken at regular intervals to allow the metal ion levels to be determined and undergo scans to allow the bone mineral density of the bone surrounding the implant to be monitored. DePuy decided to close this Study in 4Q 2009. The Study was terminated with effect from November 2010 to allow for the completion of the 5 year follow up assessments. Please note that subsequent to this decision DePuy voluntarily recalled the ASR products on 24 August 2010. Additional information regarding this voluntary recall and the follow-up of patients affected by the recall can be found at the following links http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON079157 and http://www.depuy.com/countries\_list.

Interventions

A metal-on-metal bearing surface replacement system for use in resurfacing hip arthroplasty.

Sponsors

DePuy International
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

i) Male or female subjects, aged between 18 and 65 years inclusive. ii) Subjects with current indications for standard MoM hip resurfacing arthroplasty suitable for cementless fixation in the acetabulum. These include pain, deformity, and loss of function, which are not responsive to medical treatment. iii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained. iv) Subjects, who, in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.

Exclusion criteria

i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study. ii) Subjects with proven significant osteoporosis and poor bone quality. iii) Subjects with compromised renal function. iv) Subjects with proven metal sensitivity. v) Subjects with infectious, highly communicable diseases, which may limit follow-up i.e. Active tuberculosis, hepatitis, immuno-compromised conditions, etc. vi) Women who are pregnant. vii) Subjects who are known drug or alcohol abusers or with psychological disorders that could affect follow-up care or treatment outcomes. viii) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s). ix) Subjects who are currently, or have been in the last 12 months, participating in a clinical study which involves exposure to ionising radiation. x) Subjects who are currently involved in any injury litigation claims. Additional

Design outcomes

Primary

MeasureTime frame
Kaplan-Meier survivorship at two years2 years

Secondary

MeasureTime frame
WOMAC ScoreAnnually
Activity Assessment.Annually
Kaplan-Meier survivorship calculationAnnually
UCLA Activity ScoreAnnually
Radiographic analysispre-discharge, 3mths, 1yr, 2yrs, 5yrs,10yrs and 15yrs post-surgery
Metal ion analysis in whole blood3mths, 6mths, 1yr, 2yrs and 5 yrs post-surgery
Bone mineral density (DEXA)3mths, 1yr, 2yrs and 5 yrs post-surgery
Harris Hip Scorepre-discharge, 3mths, 1yr, 2yrs, 5yrs,10yrs and 15yrs post-surgery

Countries

South Africa

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026